[Emergency prevention of influenza with remantadin].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 7148230)

Published in Zh Mikrobiol Epidemiol Immunobiol on September 01, 1982

Authors

A S Shadrin, A M Malysheva, V P Lugovskaia, M K Erofeeva, E V Oleĭnikova

Articles by these authors

Experimental and epidemiological estimation of seasonal and climato-geographical features of non-specific resistance of the organism to influenza. J Hyg Epidemiol Microbiol Immunol (1977) 1.63

[Comparative clinical trial of vaccines against avian influenza]. Zh Mikrobiol Epidemiol Immunobiol (2007) 0.78

[Study of tolerability and reactogenicity of pandemic vaccines against influenza type A/H1N1]. Zh Mikrobiol Epidemiol Immunobiol (2010) 0.77

Associated seroconversions to respiratory viruses in volunteers with experimental influenza infection. Acta Virol (1976) 0.77

[Epidemiological effectiveness of an inactivated three-component flu vaccine with an increased concentration of hemagglutinin in the inoculation dose]. Zh Mikrobiol Epidemiol Immunobiol (1992) 0.75

[Vaccine prophylaxis in elderly patients]. Zh Mikrobiol Epidemiol Immunobiol (2001) 0.75

[Experience and methods of programmed control of students' learning in various subject areas of a course in epidemiology]. Zh Mikrobiol Epidemiol Immunobiol (1969) 0.75

[Effect of serum antiviral inhibitors on resistance to influenza and acute respiratory diseases]. Vopr Virusol (1973) 0.75

[The immunoprophylaxis of influenza among elderly persons]. Zh Mikrobiol Epidemiol Immunobiol (1997) 0.75

[Dietary treatment of acute pancreatitis]. Khirurgiia (Mosk) (1971) 0.75

[Respiratory diseases according to the data of Gorlovka sanitary epidemiological center]. Vrach Delo (1976) 0.75

[Comparative study of the epidemiological efficacy of specific and nonspecific influenza preventive agents]. Zh Mikrobiol Epidemiol Immunobiol (1974) 0.75

The system of population protection against influenza. Z Erkr Atmungsorgane (1985) 0.75

[Importance of secretory antibodies in nonsusceptibility to influenza B disease and the prevention of the spread of this virus]. Zh Mikrobiol Epidemiol Immunobiol (1983) 0.75

[Assessment of the prophylactic effectiveness of an inactivated influenza vaccine by immunizing schoolchildren in the springtime]. Zh Mikrobiol Epidemiol Immunobiol (1986) 0.75

[The investigation of the safety, genetic stability and immunogenicity of live influenza vaccine for adults in vaccination of 3-6 years old children]. Vopr Virusol (2002) 0.75

[Epidemiologic approaches to diagnosis of diseases dependent on ecologic factors]. Med Tr Prom Ekol (2002) 0.75

[Evaluation of the potential use of inactivated influenza centrifuged vaccines with various hemagglutinin levels for immunizing schoolchildren]. Zh Mikrobiol Epidemiol Immunobiol (1987) 0.75

[Antineuraminidase serum antibodies in natural influenza A and immunization with influenza vaccines]. Vopr Virusol (1983) 0.75

[Clinical diagnosis of environmentally induced non-communicable diseases]. Gig Sanit (2003) 0.75

[Emergency prevention of influenza with remantadine]. Med Sestra (1984) 0.75

The present and future of specific prophylaxis of influenza and other acute viral respiratory diseases. Am Rev Respir Dis (1974) 0.75

[Organization and evaluation of the effectiveness of emergency prophylaxis and early treatment of influenza with remantadine in Serevodvinsk]. Zh Mikrobiol Epidemiol Immunobiol (1983) 0.75

[Clinico-immunologic study of the use of 2 doses of inactivated influenza centrifuge vaccine]. Tr Inst Im Pastera (1985) 0.75

[Reactogenicity and immunogenic activity of live influenza vaccines made from recombinant viruses]. Tr Inst Im Pastera (1982) 0.75

[Cardioprotective characteristics of the drug nicorandil in patients with coronary heart disease]. Ter Arkh (2011) 0.75

[The evaluation of the reactogenicity and immunological activity of an inactivated 3-component influenza vaccine with an elevated hemagglutinin concentration in the inoculation dosage]. Zh Mikrobiol Epidemiol Immunobiol (1991) 0.75

[The reactogenic properties and antigenic activity of inactivated 3-component influenza vaccines used intranasally]. Zh Mikrobiol Epidemiol Immunobiol (1994) 0.75

[Method of determination of ecologically induced actual risk for human health and the degree of stress in medical and ecological situations]. Med Tr Prom Ekol (1998) 0.75

[On the etiology and epidemiology of influenza in the north]. Sov Med (1967) 0.75

[The specific features of sociohygienic monitoring in an area of liquidation of former chemical weapons production objects]. Gig Sanit (2004) 0.75

[Etiologic structure of acute respiratory diseases in young children in the polar region]. Vopr Okhr Materin Det (1970) 0.75

[Clinical and epidemiological aspects of influenza chemoprophylaxis with bonaphthone]. Vopr Virusol (1975) 0.75

[The evaluation of the epidemiological efficacy of 3-component inactivated influenza vaccines using an intranasal application method]. Zh Mikrobiol Epidemiol Immunobiol (1994) 0.75

[Cycloferon, as an agent in the therapy and urgent prophylaxis of influenza and acute respiratory tract viral infection (multicentre randomized controlled comparative study)]. Antibiot Khimioter (2009) 0.75

[Evaluation of the effectiveness of amantadine in various respiratory infections based on the results of a serological study]. Tr Inst Im Pastera (1982) 0.75

[Combined prevention of influenza using inactivated influenza vaccine and remantadine in organized collectives of adults]. Tr Inst Im Pastera (1982) 0.75

[Viral and Mycoplasma pneumonias in children]. Pediatriia (1979) 0.75

[Results of a study of collective immunity to influenza A virus (H1N1) from 1976 to 1980]. Vopr Virusol (1982) 0.75

[Effect of a complex system of controlling influenza on a citywide scale on the etiological structure of acute respiratory diseases]. Zh Mikrobiol Epidemiol Immunobiol (1983) 0.75

[Assessment of the effectiveness of inactivated influenza vaccines for adults]. Zh Mikrobiol Epidemiol Immunobiol (1986) 0.75

[Immunogenic activity of the viral hemagglutinin and neuraminidase from live and inactivated influenza vaccines]. Zh Mikrobiol Epidemiol Immunobiol (1983) 0.75

[Organization and the results of the early ambulatory treatment of influenza patients]. Sov Med (1980) 0.75

[Antibody formation in the blood and respiratory tract secretions following one-time and repeat immunization with an inactivated influenza vaccine]. Z Erkr Atmungsorgane (1987) 0.75

[Clinical trial of new inactivated influenza vaccine "Grifor"]. Zh Mikrobiol Epidemiol Immunobiol (2009) 0.75

[IgE-response after administration of pandemic vaccine strain A/California/7/2009 (H1N1)v]. Vestn Ross Akad Med Nauk (2012) 0.75

[Formation and protective functions of antibodies to neuraminidase of the influenza A virus]. Vopr Virusol (1985) 0.75

[The current system to control influenza]. Med Sestra (1984) 0.75

[The use of the radial hemolysis reaction for demonstrating antibodies to the surface antigens of the influenza virus in assessing postvaccinal immunity]. Mikrobiol Zh (1990) 0.75

[Experience in preventing acute respiratory viral infections among the troops of the Leningrad Military District]. Voen Med Zh (1996) 0.75

[Clinical trial of safety and immunogenicity of new influenza vaccine Grifor in children]. Zh Mikrobiol Epidemiol Immunobiol (2010) 0.75

Perspectives of cooperation of CMEA countries in combatting influenza. J Hyg Epidemiol Microbiol Immunol (1982) 0.75